chr1-176864291-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004319.3(ASTN1):āc.3878A>Gā(p.Glu1293Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00333 in 1,613,990 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0025 ( 1 hom., cov: 32)
Exomes š: 0.0034 ( 21 hom. )
Consequence
ASTN1
NM_004319.3 missense
NM_004319.3 missense
Scores
4
12
Clinical Significance
Conservation
PhyloP100: 4.30
Genes affected
ASTN1 (HGNC:773): (astrotactin 1) Astrotactin is a neuronal adhesion molecule required for glial-guided migration of young postmitotic neuroblasts in cortical regions of developing brain, including cerebrum, hippocampus, cerebellum, and olfactory bulb (Fink et al., 1995).[supplied by OMIM, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0033033192).
BP6
Variant 1-176864291-T-C is Benign according to our data. Variant chr1-176864291-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2639585.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 21 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASTN1 | NM_004319.3 | c.3878A>G | p.Glu1293Gly | missense_variant | 23/23 | ENST00000361833.7 | |
ASTN1 | NM_001364856.2 | c.3902A>G | p.Glu1301Gly | missense_variant | 23/23 | ||
ASTN1 | NM_001286164.2 | c.3647+4553A>G | intron_variant | ||||
ASTN1 | XM_017001341.3 | c.3671+4553A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASTN1 | ENST00000361833.7 | c.3878A>G | p.Glu1293Gly | missense_variant | 23/23 | 1 | NM_004319.3 | P1 | |
ASTN1 | ENST00000367657.7 | c.3647+4553A>G | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00251 AC: 382AN: 152166Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
382
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00236 AC: 592AN: 251024Hom.: 6 AF XY: 0.00237 AC XY: 321AN XY: 135634
GnomAD3 exomes
AF:
AC:
592
AN:
251024
Hom.:
AF XY:
AC XY:
321
AN XY:
135634
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00341 AC: 4989AN: 1461706Hom.: 21 Cov.: 33 AF XY: 0.00332 AC XY: 2414AN XY: 727168
GnomAD4 exome
AF:
AC:
4989
AN:
1461706
Hom.:
Cov.:
33
AF XY:
AC XY:
2414
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00251 AC: 382AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.00240 AC XY: 179AN XY: 74462
GnomAD4 genome
AF:
AC:
382
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
179
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
15
ALSPAC
AF:
AC:
17
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
40
ExAC
AF:
AC:
282
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
ASTN1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 13, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | ASTN1: BP4, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at